if switching from semaglutide to tirzepatide Tirzepatide: Is It a Good Idea? How to Switch from Tirzepatide

While the EXSCEL and SUMMIT trials have shown some concerns over selective outcome reporting

The right choice depends on whether the patients main issue is visceral fat, appetite, under-recovery, low exercise tolerance, slow healing, or age-related decline in lean tissue support

Concurrent federal action will provide the most robust protection against all the illegal and deceptive conduct. The statements issued by medical societies and government officials are important not just for health care professionals, but also for educating patients about how obesity management should be approached, according to Sangeeta Kashyap, MD, assistant chief of clinical affairs in the department of endocrinology, diabetes and metabolism at NewYork-Presbyterian/Weill Cornell Medical Center and a Healio | Endocrine Today Co-editor

These innovations improve adherence and broaden therapeutic use

doi: 10.4103/indianjpsychiatry.indianjpsychiatry_499_24